Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

Lignende værker

• Impact of additional cytoreduction following autologous SCT in multiple myeloma
  af: Kumar, SK, et al.
  Udgivet: (2008)
• Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents
  af: Majithia, N, et al.
  Udgivet: (2016)
• Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma
  af: Srivastava, G, et al.
  Udgivet: (2013)
• Idiotype-pulsed antigen presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival
  af: Lacy, Martha Q., et al.
  Udgivet: (2009)
• Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma
  af: Short, K Detweiler, et al.
  Udgivet: (2011)